Skip to main content
UTHH-UTP Logo

Alert!

There has been an error in displaying this message. Please contact the site administrator.

News & Articles

UTHealth Houston Research

May 8, 2026

Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments, UTHealth Houston researchers find

Written By: Catherine Marfin | Updated: May 8, 2026
A peptide that successfully targeted and killed metastatic cancer cells in mice may open the door to developing more efficient ways to detect and treat metastatic breast cancer in humans, UTHealth Houston researchers have discovered. 
May 8, 2026

Tumor-on-a-chip brings new insight to pancreatic cancer

Written By: Roman Petrowski | Updated: May 8, 2026
Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation. Instead, they are surrounded by a dense and complex network of blood vessels, connective tissue, and immune cells that shape how the disease grows and responds to therapy.
May 8, 2026

UTHealth Houston awarded nearly $8 million to research brain processes underlying Parkinson’s disease

Written By: Catherine Marfin | Updated: May 8, 2026
Researchers at UTHealth Houston have been awarded a three-year, $7.8 million grant from the Aligning Science Across Parkinson’s initiative to support projects that will help health professionals better understand how Parkinson’s disease occurs in the brain. 
April 23, 2026

Houston man becomes first in Texas to receive innovative treatment-resistant depression therapy at UTHealth Houston

Written By: Catherine Marfin | Updated: April 23, 2026
UTHealth Houston has become the first health center in Texas to offer Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT, an FDA-approved form of transcranial magnetic stimulation for treatment-resistant depression. 
April 20, 2026

New UTHealth Houston center will focus on congenital heart disease breakthroughs

Written By: Roman Petrowski | Updated: April 20, 2026
A new multidisciplinary center at McGovern Medical School at UTHealth Houston is bringing together experts across medicine, science, and engineering to transform how congenital heart disease is understood and treated across a patient’s lifetime.
April 20, 2026

UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation

Written By: Jeannette Sanchez | Updated: April 20, 2026
CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly.
April 10, 2026

Risk of Alzheimer’s dementia significantly reduced after high-dose influenza vaccination compared to the standard dose, study finds

Written By: Sydney Lowther | Updated: April 10, 2026
The risk of Alzheimer’s disease significantly decreases in older adults who receive a higher dose of the influenza vaccine compared to the standard dose, according to new research led by UTHealth Houston. 
April 10, 2026

Understanding language requires communication between multiple brain regions, UTHealth Houston researchers discover

Written By: Catherine Marfin | Updated: April 10, 2026
Multiple regions of the brain engage in fast-moving conversations to understand language, UTHealth Houston researchers have discovered, dispelling a prior school of thought that only one region of the brain was responsible for language processing.
April 10, 2026

Heart disease risk spikes with ultraprocessed foods, study finds

Written By: Sydney Lowther | Updated: April 10, 2026
Daily consumption of more than nine servings of ultraprocessed foods increased the risk of suffering from a major cardiac event by 67%, according to new research led by UTHealth Houston.
March 11, 2026

At the Bedside: First baby to receive novel spina bifida surgery at UTHealth Houston thriving 6 months after treatment

Written By: Catherine Marfin | Updated: March 11, 2026
Six months after receiving a groundbreaking, experimental new surgery for spina bifida at UTHealth Houston, Nova continues to flourish. 

Categories

Categories

Find a Doctor/Provider

Find Locations

Patient Care

Careers

Patient Info

Why UT Physicians